NEWS
Our Latest News
ARCHIMED’s MED II sells DIESSE, returning 4.6x to shareholders
ARCHIMED’s MED II sells DIESSE, returning 4.6x to shareholders
Private equity healthcare specialist ARCHIMED announces the sale of DIESSE to private equity firm Fremman Capital. The transaction caps a five-year partnership with DIESSE and marks the latter’s transformation into a leading clinical diagnostics innovator. The deal returns 4.6 times invested capital to shareholders.
ARCHIMED’s Direct Healthcare Group acquires Talley
March
3,
2021
Acquisition by ARCHIMED’s NAMSA makes it the preeminent contract research organization for medtech lab testing
March
2,
2021
ARCHIMED strengthens its North American capabilities
January
26,
2021
ARCHIMED’s Direct Healthcare Group sees annual revenue more than double through four Buy-and-Build purchases over nine months
January
25,
2021
368